Financial statements Gj Pharma
Balance sheet of Gj Pharma
Company age:
Age:
6 y. 5 m. 11 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of GJ PHARMA
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 430 204,48 | 718 473,46 | 323 448,15 |
| A. Fixed assets | 32 000,08 | 24 000,16 | 8 000,32 |
| B. Current assets | 398 204,40 | 694 473,30 | 315 447,83 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 430 204,48 | 718 473,46 | 323 448,15 |
| A. Equity | 331 447,88 | 206 778,03 | 115 404,63 |
| B. Liabilities and provisions for liabilities | 98 756,60 | 511 695,43 | 208 043,52 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.